Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 2 of 18
Health
‘They knew what the harm was. They did it anyway’: Johnson & Johnson pays $149.5 million to Washington state over opioids
By
Manuel Valdes
,
Hallie Golden
and
The Associated Press
January 24, 2024
Health
‘They see a cash cow’: State and local officials overseeing billions in opioid settlements are deluged with product offers from companies hoping to cash in
By
Aneri Pattani
and
KFF Health News
December 18, 2023
Newsletters
A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?
By
Emma Hinchliffe
and
Joey Abrams
December 7, 2023
Newsletters
J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand
By
Market Analyst
December 7, 2023
Newsletters
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO
By
Trading Desk
December 6, 2023
Finance
13 inflation-proof stocks to buy for 2024
By
Will Daniel
and
Scott DeCarlo
November 28, 2023
Health
Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing
By
Jef Feeley
and
Bloomberg
October 26, 2023
Leadership
Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato
By
News Correspondent
October 11, 2023
Finance
J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation
By
Tech Reporter
October 3, 2023
Health
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
By
Jef Feeley
and
Bloomberg
September 28, 2023
Health
McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
By
Joel Rosenblatt
and
Bloomberg
September 27, 2023
Newsletters
This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business
By
Emma Hinchliffe
and
Joey Abrams
September 15, 2023
Health
The top decongestant on the market doesn’t actually decongest, FDA says
By
Matthew Perrone
and
The Associated Press
September 12, 2023
Health
Tylenol poisoning suspect who tried to extort $1 million from Johnson & Johnson to ‘stop the killing’ dies at 76
By
Mark Pratt
and
The Associated Press
July 11, 2023
Leadership
From free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9 companies are competing on A.I. talent
By
Staff Writer
June 26, 2023
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Financial Writer
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Editorial Team